10-Q: Cinemark Holdings Reports Q1 2025 Results: Revenue Declines Amid Industry Box Office Slowdown

Cinemark Holdings' Q1 2025 revenue decreased due to a weaker industry box office, though strategic pricing initiatives and concession performance provided some offset.

Summary

• Cinemark Holdings reported a net loss of $38.6 million for the first quarter of 2025, compared to a net income of $25.3 million in the same period of 2024.
• Total revenue decreased by 6.6% to $540.7 million, primarily due to a decline in admissions revenue.
• The U.S. market saw a 12.7% decrease in attendance, while the international market remained relatively stable.
• Strategic pricing initiatives led to a 2.6% increase in average ticket price in the U.S.
• Concession revenue per patron increased by 1.8% to $5.75.
• The company repurchased $200 million of its outstanding stock under a share repurchase program.
• A quarterly dividend of $0.08 per share was reinstated.
• As of March 31, 2025, Cinemark operated 497 theaters with 5,644 screens worldwide.
• The company expects to repay the principal amount of its 4.50% Convertible Senior Notes upon maturity in August 2025, potentially settling the remainder with shares.

Sentiment

Score: 4

Explanation: The report presents a mixed picture. While strategic pricing and concession performance showed positive trends, overall financial results were negatively impacted by a weaker industry box office and increased expenses. The company's outlook is cautiously optimistic, with plans to manage debt and continue shareholder returns.

Positives

• Strategic pricing initiatives led to a 2.6% increase in average ticket price in the U.S.
• Concession revenue per patron increased by 1.8% to $5.75.
• The company repurchased $200 million of its outstanding stock under a share repurchase program.
• A quarterly dividend of $0.08 per share was reinstated.
• In constant currency, international average ticket price increased 13.1% and concession revenue per patron increased 15.2%.

Negatives

• Q1 2025 revenue decreased by 6.6% year-over-year to $540.7 million.
• Net loss for Q1 2025 was $38.6 million, compared to a net income of $25.3 million in Q1 2024.
• U.S. attendance decreased by 12.7% to 20.6 million patrons.
• Equity in income of affiliates decreased from $3.8 million to $0.9 million.
• Net loss on investment in NCMI was $3.6 million, compared to a gain of $4.4 million in the prior year.

Risks

• The success of the theatrical exhibition industry is contingent upon the volume of new film content available, which is continuing to recover from the effects of the COVID-19 pandemic and most recently the writers and actors guilds strikes (the Hollywood strikes).
• Labor market conditions and inflationary pressures have driven increases in wage rates across our labor base and similar increases may continue in the future.
• The company is involved in various legal proceedings arising from the ordinary course of its business operations.
• The company's 4.50% Convertible Notes are effectively subordinated to any of Holdings, or its subsidiaries, existing and future secured debt to the extent of the value of the assets securing such indebtedness, including obligations under the Credit Agreement.

Future Outlook

The company expects to repay the principal amount of its 4.50% Convertible Senior Notes upon their maturity in August 2025, potentially settling the remainder with shares. The company anticipates paying regularly quarterly cash dividends on its common stock, subject to available cash balances, anticipated cash needs, overall financial condition, loan agreement restrictions, and future prospects for earnings and cash flows.

Industry Context

The report acknowledges the theatrical exhibition industry's dependence on the volume and performance of new film content, the duration of exclusive theatrical release windows, and evolving consumer behavior, including competition from streaming services.

Comparison to Industry Standards

• The North American Industry box office generated approximately $1.5 billion during the 2025 period, which included new releases Captain America: Brave New World, Dog Man, Disneys Snow White, One of Them Days and Paddington in Peru , as well as the carryover of 2024 releases Mufasa: The Lion King, Sonic the Hedgehog 3, Moana 2, Nosferatu, and A Complete Unknown .
• The North American Industry box office was approximately $1.7 billion during the 2024 period, which included new releases Dune: Part Two, Kung Fu Panda 4, Bob Marley: One Love, Godzilla x Kong: The New Empire, Ghostbusters: Frozen Empire, Mean Girls and The Beekeeper, as well as the carryover of 2023 releases Wonka , Migration and Anything But You.

Legal Proceedings

• Gerardo Rodriguez, individually and on behalf of a class of all others similarly situated vs Cinemark USA, Inc. and Cinemark Holdings, Inc., et al.
• Shane Waldrop, individually and on behalf of all other similarly situated, vs. Cinemark USA, Inc.
• Latishma Narayan, individually and on behalf of others similarly situated vs. Cinemark USA, Inc., Century Theatres, Inc., et al.

Related Party Transactions

• A subsidiary of the Company manages a theater for Laredo Theatre, Ltd.
• A subsidiary of the Company leases 12 theaters from Syufy Enterprises, LP (Syufy) or affiliates of Syufy.
• A subsidiary of the Company has a 50 % voting interest in FE Concepts, a joint venture with AWSR.

Stakeholder Impact

• Shareholders will receive a quarterly dividend of $0.08 per share.
• Employees may be affected by wage and benefit inflation.
• Customers may experience changes in pricing and promotional activities.

Next Steps

• The company expects to repay the principal amount of its 4.50% Convertible Senior Notes upon their maturity in August 2025, potentially settling the remainder with shares.
• Holdings, at the discretion of its Board of Directors and subject to applicable law, anticipates paying regularly quarterly cash dividends on its common stock.

Key Dates

Keywords

Cinemark, revenue, attendance, box office, concessions, dividends, share repurchase, Q1 2025, theaters, film